NCT03278847

Brief Summary

The overarching aim of this project is to determine the optimum enteral and parenteral nutrition strategy for newborns with Hypoxic Ischaemic Encephalopathy (HIE) during and after therapeutic hypothermia. To do this the investigators will perform two primary comparisons:

  1. 1.ENTERAL: to determine whether any enteral (milk) feeding, when compared to withholding enteral feeding (no milk), during therapeutic hypothermia, is associated with a difference in the incidence of necrotising enterocolitis.
  2. 2.PARENTERAL: to determine whether provision of intravenous dextrose, when compared to provision of parenteral nutrition, during therapeutic hypothermia, is associated with a difference in the incidence of blood stream infection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,030

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
7.6 years until next milestone

First Submitted

Initial submission to the registry

August 23, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 12, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

September 14, 2023

Completed
Last Updated

September 14, 2023

Status Verified

November 1, 2022

Enrollment Period

8 years

First QC Date

August 23, 2017

Results QC Date

September 20, 2021

Last Update Submit

November 7, 2022

Conditions

Keywords

NNRDmatchingpropensity score

Outcome Measures

Primary Outcomes (2)

  • Necrotising Enterocolitis - for the Enteral Nutrition Comparison

    Defined according to the case definition of Battersby et al., 2017, JAMA Pediatrics

    From date of birth until date of final neonatal unit discharge, assessed up to 1 year

  • Blood Stream Infection - for the Parenteral Nutrition Comparison

    defined according to the Healthcare Quality Improvement Partnership (HQIP) National Neonatal Audit Programme (NNAP) case definition: pure growth of a recognised pathogen from a normally sterile site

    From date of birth until date of final neonatal unit discharge, assessed up to 1 year

Secondary Outcomes (6)

  • Survival

    From date of birth until date of final neonatal unit discharge, assessed up to 1 year

  • Length of Stay

    From date of birth until date of final neonatal unit discharge, assessed up to 1 year

  • Breastfeeding

    At the point of final discharge from neonatal care, assessed up to 1 year

  • Hypoglycaemia

    From date of birth until date of final neonatal unit discharge, assessed up to 1 year

  • Duration of Central Venous Line

    From date of birth until date of final neonatal unit discharge, assessed up to 1 year

  • +1 more secondary outcomes

Study Arms (2)

Enteral nutrition comparison

This comparison refers to differences in enteral nutrition during therapeutic hypothermia

Dietary Supplement: Received enteral (milk) feeds during therapeutic hypothermiaDietary Supplement: Enteral (milk) feeds withheld during therapeutic hypothermia

Parenteral nutrition comparison

This comparison refers to differences in parenteral nutrition during therapeutic hypothermia

Dietary Supplement: Received parenteral nutrition during therapeutic hypothermiaDietary Supplement: Did not receive parenteral nutrition during therapeutic hypothermia

Interventions

In the enteral component of nutrition, the health technology to be assessed is the gradual introduction of enteral (milk) feeds during therapeutic hypothermia: * Included in this is any type of milk (e.g. expressed maternal breast milk, expressed donor breast milk and artificial formula) * This health technology includes different routes of administering enteral feeds such as nasogastric tube (gavage feeding) and bottle * This health technology also includes different rates of increasing enteral feeds (for example by 15ml/kg/day, by 30ml/kg/day or faster)

Enteral nutrition comparison

Withholding enteral feeds (keeping a baby nil per os) for the duration of hypothermia.

Enteral nutrition comparison

In the parenteral component, the health technology being assessed is administration of parenteral nutrition during therapeutic hypothermia: * Included in this are different compositions of parenteral nutrition (for example standard, pre-prepared bags of nutrition and individually tailored parenteral nutrition) * This health technology includes different routes of administration of parenteral nutrition such as via a peripheral intravenous cannula, percutaneous central venous catheter ('long line') or umbilical venous catheter. * This health technology also includes different volumes of parenteral nutrition (e.g. 40ml/kg/day, 60ml/kg/day or greater).

Parenteral nutrition comparison

Received standard intravenous fluids (10% dextrose with additional electrolytes added where required) for the duration of hypothermia.

Parenteral nutrition comparison

Eligibility Criteria

AgeUp to 4 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Infants born at 36 gestational weeks or later who received therapeutic hypothermia for Hypoxic Ischaemic Encephalopathy (HIE) for least 72 hours, or who died during therapeutic hypothermia.

You may qualify if:

  • Received neonatal care at a unit that is part of the UK Neonatal Collaborative; this includes all NHS neonatal units in England, Scotland and Wales
  • Recorded gestational age at birth ≥36 weeks
  • Recorded as receiving therapeutic hypothermia for 72 hours or died during therapeutic hypothermia

You may not qualify if:

  • \. Infants with missing data for principal background and outcome variables.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Chelsea and Westminster Hospital and NHS Foundation Trust

London, SW10 9NH, United Kingdom

Location

Imperial College London, Chelsea and Westminster Hospital campus

London, SW10 9NH, United Kingdom

Location

Related Publications (4)

  • Battersby C, Longford N, Patel M, Selby E, Ojha S, Dorling J, Gale C. Study protocol: optimising newborn nutrition during and after neonatal therapeutic hypothermia in the United Kingdom: observational study of routinely collected data using propensity matching. BMJ Open. 2018 Oct 23;8(10):e026739. doi: 10.1136/bmjopen-2018-026739.

    PMID: 30355795BACKGROUND
  • Gale C, Jeyakumaran D, Longford N, Battersby C, Ojha S, Oughham K, Dorling J. Administration of parenteral nutrition during therapeutic hypothermia: a population level observational study using routinely collected data held in the National Neonatal Research Database. Arch Dis Child Fetal Neonatal Ed. 2021 Nov;106(6):608-613. doi: 10.1136/archdischild-2020-321299. Epub 2021 May 5.

    PMID: 33952628BACKGROUND
  • Gale C, Longford NT, Jeyakumaran D, Ougham K, Battersby C, Ojha S, Dorling J. Feeding during neonatal therapeutic hypothermia, assessed using routinely collected National Neonatal Research Database data: a retrospective, UK population-based cohort study. Lancet Child Adolesc Health. 2021 Jun;5(6):408-416. doi: 10.1016/S2352-4642(21)00026-2. Epub 2021 Apr 21.

  • Gale C, Jeyakumaran D, Battersby C, Ougham K, Ojha S, Culshaw L, Selby E, Dorling J, Longford N. Nutritional management in newborn babies receiving therapeutic hypothermia: two retrospective observational studies using propensity score matching. Health Technol Assess. 2021 Jun;25(36):1-106. doi: 10.3310/hta25360.

MeSH Terms

Conditions

Asphyxia NeonatorumHypothermiaHyperphagiaEnterocolitis, NecrotizingNeonatal Sepsis

Interventions

Milk

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, DigestiveEnterocolitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesSepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic Processes

Intervention Hierarchy (Ancestors)

BeveragesDiet, Food, and NutritionPhysiological PhenomenaDairy ProductsFoodFood and Beverages

Results Point of Contact

Title
Dr Chris Gale, Reader in Neonatal Medicine
Organization
Imperial College London

Study Officials

  • Chris Gale, MBBS, PhD

    Imperial College London

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2017

First Posted

September 12, 2017

Study Start

January 1, 2010

Primary Completion

December 31, 2017

Study Completion

January 1, 2021

Last Updated

September 14, 2023

Results First Posted

September 14, 2023

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will share

All study data will be extracted from the National Neonatal Research Database (NNRD). The NNRD has been created through the collaborative efforts of neonatal services across the country to be a national resource. The NNRD is maintained and managed at the Neonatal Data Analysis Unit (NDAU) at Imperial College London and Chelsea and Westminster NHS Foundation Trust. Researchers, clinicians, managers, commissioners, and others are welcome and encouraged to utilise the NNRD.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
The NNRD holds data from 2007 to present.
Access Criteria
Access criteria and guidance is found at the URL below
More information

Locations